Annual report pursuant to Section 13 and 15(d)

Accrued Expenses (Tables)

v3.19.2
Accrued Expenses (Tables)
12 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of accrued expenses
    March 31,
    2019   2018
         
 Accrued AV-101 clinical trial, development, and                
      related expenses   $ 1,067,600     $ 176,600  
 Accrued compensation     439,200       —    
 Accrued professional services     172,100       27,000  
 All other     6,700       2,700  
                 
    $ 1,685,600     $ 206,300